Back to results
US 6,333,359 B1Granted
Regulation of cellular apoptosis using modulators of β-AR receptors
AssigneeInstitut National De La Sante Et De La Recherche Medicale (Inserm)
InventorsJean-Gérard Guillet, Claudine Andre, Pascale Briand
Life of this patent
Estimating the term…
Abstract
The invention concerns the use of β2-adrenergic modulators for regulating cellular apoptosis.
Claims6
A method of treatment of a patient in need of regulation of cellular apoptosis comprising administration of an effective amount of a β2-AR receptor modulator to a patient in need thereof.
Dependencies are inferred from the claim text.